Peptic Ulcer Drugs Market, by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonist, Antibiotics, Ulcer Protective) by Disease Indication (Gastitis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflu

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	204 Pages	Coherent Market Insights	March, 2025	CMI20004801

Best Price Guarantee
Price	from $4,500
Length	204 Pages
Publisher	Coherent Market Insights
Published Date	March, 2025
SKU	CMI20004801

Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain. Peptic ulcers include: Gastric ulcers that occur on the inside of the stomach and Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum). The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Stress and spicy foods do not cause peptic ulcers. However, they can make your symptoms worse.

The most common peptic ulcer symptom is burning stomach pain. Stomach acid makes the pain worse, as does having an empty stomach. Peptic ulcer disease occurs when open sores, or ulcers, form in the stomach or first part of the small intestine. Many cases of peptic ulcer disease develop because a bacterial infection eats away the protective lining of the digestive system. People who frequently take pain relievers are more likely to develop ulcers.

Market Dynamics

An increase in product approval from the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in December 2021, Edenbridge Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration have approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of a peptic ulcer and as an adjunct to treatment of peptic ulcers.

Key features of the study:

This report provides an in-depth analysis of the global peptic ulcer drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptic ulcer drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global peptic ulcer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptic ulcer drugs market

Detailed Segmentation:

Global Peptic Ulcer Drugs Market, By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonist
Antibiotics
Ulcer Protective
Global Peptic Ulcer Drugs Market, By Disease Indication:
Gastitis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
Global Peptic Ulcer Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peptic Ulcer Drugs Market, By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
Daewoong Pharmaceutical Co., Ltd
Takeda Pharmaceutical Co., Ltd.
Pfizer Inc.
AstraZeneca plc.
RedHill Biopharma
Cadila Healthcare Ltd.
Novitium Pharma LLC.
Boehringer Ingelheim GmbH
Eisai Co. Ltd.
Yuhan Corporation
GlaxoSmithKline plc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Disease Indication; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis; Pipeline Analysis
4. Global Peptic Ulcer Drugs Market- Impact of Coronavirus (Covid-19) Pandemic: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Peptic Ulcer Drugs Market, By Product Type, 2020 – 2032, (US$ Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Proton Pump Inhibitors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Potassium-Competitive Acid Blocker (P-CAB); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Antacids; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); H2- Antagonists; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Antibiotics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Ulcer Protective; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
6. Global Peptic Ulcer Drugs Market, By Disease Indication, 2020 – 2032, (US$ Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Gastitis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Gastric Ulcer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Duodenal Ulcer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Gastroesophageal Reflux Disease (GERD); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
7. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2020 – 2032, (US$ Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
8. Global Peptic Ulcer Drugs Market, By Region, 2020 – 2032, (US$ Billion): Overview; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Regions, 2021–2032; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (US$ Billion); North Africa; Central Africa; South Africa
9. Competitive Landscape: Daewoong Pharmaceutical Co., Ltd.*; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Takeda Pharmaceutical Co., Ltd.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Pfizer Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; AstraZeneca plc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; RedHill Biopharma; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Cadila Healthcare Ltd.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Novitium Pharma LLC.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Boehringer Ingelheim GmbH; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Eisai Co. Ltd.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Yuhan Corporation; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; GlaxoSmithKline plc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies
10. Section: Research Methodology; About Us; *Browse 25 market data tables and 27 figures on “Global Peptic Ulcer Drugs Market” - Global forecast to 2032